Home > Press > Microfluidics Introduces New Services Designed to Enhance Customer Success
Abstract:
Microfluidics, a division of Microfluidics International Corporation (OTCBB: MFLU), announces the availability of several new services designed to enhance customer success and assist in customer innovation. These new services build on the deep technology, process and applications expertise that Microfluidics has developed through its 25 years of experience with thousands of customer applications, including the company's hands-on work with formulations at the Microfluidics Technology Center.
The new services include process consulting, customized in-house seminars and training, and preventive maintenance contracts. Process consulting and customized seminars/training are delivered by Microfluidics' Chief Technology Officer, Mimi Panagiotou, and the company's technical staff members. Preventive maintenance is provided by highly-skilled field service engineers.
"Because our customers' challenges and opportunities continue to evolve, we're expanding the ways in which we support their technical innovations and subsequent commercial success," noted Mary Anne North, Microfluidics' Vice President of Customer Success. "Through these new services, we are helping our customers to understand and capitalize on new technologies, and to optimize their development and production processes."
These new services further expand Microfluidics' portfolio of customer services and support. Prior to purchase, Microfluidics provides qualified prospects with complimentary processing of a lab sample at its Microfluidics Technology Center. It also offers on-site demonstrations, regional seminars and rental options. After its customers invest in a Microfluidizer® processor, Microfluidics ensures their successful ongoing use via pharmaceutical-specific acceptance testing, startup and installation training, technical services and a full range of parts.
Process consulting
Through its process consulting services, Microfluidics helps its customers to develop processes for nanomaterial production and then optimize those processes while scaling up from lab to pilots and full-scale production. Its highly-trained technical staff members have advised many customers and provide consulting services ranging from proof of concept to optimization and scale-up.
Examples of topics for process consulting include:
* Assistance with formulation development and material characterization
* Proof of concept for single formulations addressing a variety of process parameters (shear rate, temperature, etc.) This may include hands-on lab work.
* Product optimization for multiple formulations. This may include hardware optimization and lab work.
* Scale-up, including hardware optimization on a large scale
* Process intensification
Customized in-house seminars and training
Microfluidics' technical staff members stay current on nanotechnology developments and a wide range of other promising technologies and applications, and use that expertise to deliver customized in-house seminars and training.
Examples of topics for seminars and training include:
* Seminars tailored for each customer covering all aspects of the Microfluidizer technology and discussing its use in relation to the customer's unique needs. This may include hands-on training if requested.
* Briefings on specific applications or new technologies, tailored for each customer on topics such as bio-pharma, energy chemicals, digital inks, etc.
* Overview seminars on nanotechnology (synthesis, processing, applications), possibly including outside speakers
Preventive maintenance contracts
Microfluidics' preventive maintenance contracts provide customers with the ease of pre-arranging their annual preventive maintenance, through single- or multiple-year contracts, in order to ensure the longevity and optimal performance of their Microfluidizer processors. A Microfluidics preventive maintenance visit to a customer site by a skilled field service engineer includes processor inspection, replacement of designated parts, a performance test, a written report of processor condition and recommendations, and brief training in various processor procedures.
####
About Microfluidics
Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation, is a supplier of advanced fluid processing equipment and reaction technology for laboratory, pilot scale and manufacturing applications. The equipment enables the manufacture and formulation of numerous nanomaterials and nanoscale products and produces the most uniform and smallest liquid and suspended solid particles available.
Microfluidics has been a worldwide supplier of Microfluidizer® high shear fluid processing systems to the biotechnology, pharmaceutical, chemical, cosmetics/personal care and food industries since 1984. As a leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate and produce licensed drugs for the worldwide healthcare market.
Companies seeking to produce difficult-to-formulate products or to find better methods of bio-processing can take advantage of complimentary sample testing at one of three Microfluidics facilities. Visit www.microfluidicscorp.com, email or contact Microfluidics at 800.370.5452 for application information.
For more information, please click here
Contacts:
Gray & Rice Public Relations
Katie DePorter
617-747-1795
Copyright © Business Wire 2008
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Microfluidics/Nanofluidics
Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023
Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022
Oregon State University research pushes closer to new therapy for pancreatic cancer May 6th, 2022
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||